Articles filed under Clinical Trial, newest first.
Featured
Biologic medicines changed modern healthcare. They treat complex diseases like cancer, autoimmune disorders, and diabetes.
Read article
Pharma R&D waste is often mistaken for scientific failure. In reality, a large portion of it is strategic and preventable.
Read article
The generic injectable market is not glamorous. It is not trendy either. But it prints money.
Read article
The biosimilar market is getting bigger, faster, and honestly a little chaotic. Patent cliffs are coming one after another, biologics are losing exclusivity across the world, and every pharma company wants a piece of the action.
Read article
Bottom line is, 2026 will is going to be one of the most important years for healthcare sector. So let’s dive in, and get a better look at what next year have up it’s sleeves.
Read articlePage 4 of 13 · 61 articles